S
Star Vision Research | Burleson, TX
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Tarcocimab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 1 total trial
This study will demonstrate that tarcocimab 5 mg is superior to sham treatment in participants with moderately severe to severe NPDR.
Enrolling
Non-proliferative Diabetic Retinopathy
Drug: Tarcocimab
Other: Sham injection
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems